Early Phase 1
N=10
Investigation of the Glycemic Index of Ethiopian Honey
Hyperglycemia, Postprandial
Bottom Line
View on ClinicalTrials.gov: NCT02488018 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcome: Primary: Examine Effect of Monofloral Honey Types on Glycemic Index of Health Human Subjects — 54.73; 62.82; 60.31; 59.54 Index — p=<0.01
Study Design & Population
- Study type
- Interventional
- Phase
- Early Phase 1
- Interventions
- Provision of experimental honey (Biological)
- Age
- Adult · 20+ yrs
- Sex
- All
- Sponsor
- Addis Ababa University
- Primary completion
- Nov 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Examine Effect of Monofloral Honey Types on Glycemic Index of Health Human Subjects |
54.73; 62.82; 60.31; 59.54; 63.22; 64.06 | <0.01 sig |
Summary
The purpose of this study is to determine which of the Ethiopian honeys slowly/rapidly raise the blood glucose level.
Eligibility Criteria
Inclusion Criteria
- Clinical diagnosis of diabetes Disease
- Must be able to drink the honeys and reference glucose
Exclusion Criteria
- Overweight, dieting, smoking, a family history of diabetes, pregnant, metabolic disorders, suffering from any illness or food allergy and regularly taking medication.
Data sourced from ClinicalTrials.gov (NCT02488018). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.